In this session, we will be presenting our team’s findings on oncology approvals across agencies and programs, and the impact of Project Orbis since it was established. This presentation will include a detailed review of reconstructed development timelines before and after Project Orbis, along with an analysis of the conditions and events that contributed to regulatory decisions.
Learning Objectives:
Discuss the impact of Project Orbis since it was established
Compare drug development strategies and regulatory decision timelines in oncology, before and after Project Orbis
Understand the conditions and events that led to regulatory decisions